Overview Brain arteriovenous malformations (bAVM) are dynamic vascular lesions that can grow, and in some cases grow back (recur) after treatment. The factors that cause these vessels to grow, recur, or rupture are not well understood, especially in the pediatric population where it has been reported that 20% of cases can recur after definitive surgical resection within 5 years. By understanding when AVM features develop, doctors will be better able to monitor and develop new drug treatments for bAVM, which do not currently exist. The purpose of this study is to identify imaging characteristics and blood markers that may explain how these blood vessels grow or change over time. We are prospectively enrolling pediatric bAVM cases, collecting blood samples at multiple visits, and following them annually with advanced research images in addition to standard clinical images. This project is one of three projects awarded to the UCSF Center of Excellence in Hemorrhagic Stroke Research. For more information about the studyFor more information about AVM or support groupsTo request a clinic appointment Affiliated Lab Center for Cerebrovascular Research Principal investigator UCSF Helen Kim, MPH, PhD Professor in Residence External persons Heather Fullerton, MD, MAS Professor of Neurology, UCSF Center Director and Training Director, UCSF Center of Excellence in Hemorrhagic Stroke Research Seeking collaborators Our project is looking for individuals to join our team. Get in touch if you’d like to learn more. Email Us Support this research Are you excited by the innovative work we’re doing on this project? Learn how your financial support can make the difference in our work. Support
Center for Cerebrovascular Research Cerebral hemorrhage risk in hereditary hemorrhagic telangiectasia (BVMC 6203)
Center for Cerebrovascular Research Cellular loci involved in the pathogenesis of brain arteriovenous malformations
Center for Cerebrovascular Research Modifiers of disease severity and progression in familial cerebral cavernous malformation (BVMC 6201)
Center for Cerebrovascular Research Integrated longitudinal studies to identify biomarkers and therapeutic strategies for Sturge-Weber Syndrome (BVMC 6211)
Center for Cerebrovascular Research IL-6 trans-signaling increases risk for perioperative neurocognitive disorders in aging and neurodegenerative diseases
Center for Cerebrovascular Research Detection of somatic mutations in cerebral cavernous malformation patients using non-invasive cell-free DNA screening
Center for Cerebrovascular Research Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH)
Center for Cerebrovascular Research Epigenetic signatures and association with hemorrhage and high risk features in brain arteriovenous malformation
Center for Cerebrovascular Research Investigating disparities and barriers in access to research and care for patients with Hereditary Hemorrhagic Telangiectasia (HHT)
Center for Cerebrovascular Research Reduction of brain AVM severity through inhibition of pathogenic angiogenesis